PATENT CLAIM ANALYSIS

Application Number: 16058769
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "468000"]

Abstract:
The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.

Claim (Index 7):
The controlled release oral dosage formulation of  claim 1 , wherein the aplindore, or the pharmaceutically acceptable salt thereof, is released at a rate to provide an AUC 0-12  of at least about 1.2 times that of the instant release formulation.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 96.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15912438', '13498751', '11846896', '10269551', '14555475']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6649949960559396
- 35 USC 102 Novelty (BERT): 0.6158456142232143
- Combined Prediction Score: 0.660080057872667
- Mean Citation Score: 331.0705559999999
- Max Citation Score: 532.80304
- Similarity Product: 504.7354121657753

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test